PubMed Central (PMC3 - NLM DTD)
(2,081,148 recursos)
Archive of life sciences journal literature at the U.S. National Institutes of Health (NIH), developed and managed by NIH's National Center for Biotechnology Information (NCBI) in the National Library of Medicine (NLM).
192.
EVERSION ENDARTERECTOMY: A NEW APPLICATION OF AN OLD TECHNIQUE - Treadwell, Terry; Korompai, Ferenc L.; Hayward, Ronald H.
Restoration of arterial flow to a severely ischemic extremity remains a major challenge in vascular surgery. The procedure of choice for limb salvage is a bypass utilizing reversed saphenous vein. When the saphenous vein is unsuitable or unavailable, the surgeon must turn to endarterectomy of the femoral and popliteal systems or synthetic, composite, heterologous, autologous, or homologous grafts. To avoid the problems associated with these techniques and to improve the results of limb salvage, we have revived and modified the technique of superficial femoral artery eversion endarterectomy and combined it with other reconstructive techniques in an effort to salvage the...
194.
ABSENCE OF THE LEFT PERICARDIUM, SPONTANEOUS PNEUMOTHORAX, AND PATENT DUCTUS ARTERIOSUS - Rees, J. Richard
A 19-year-old male patient with congenital absence of the left pericardium, spontaneous pneumothorax, and a patent ductus is presented. The diagnosis of absence of the left pericardium was made at operation but should have been entertained preoperatively because of the concomitant occurrence of a left spontaneous pneumothorax.
199.
LOW PROFILE BIOPROSTHESIS FOR CARDIAC VALVE REPLACEMENT: EARLY CLINICAL RESULTS - Liotta, Domingo; Bracco, Daniel; Ferrari, Helio; Bertolozzi, Enrique; Pisanu, Amadeo; Donato, Osvaldo
Between May 1976 and April 1977, 100 patients underwent cardiac valve replacement with a unique low profile glutaraldehyde-treated porcine aortic xenograft. These patients were classified in four groups: Group I, 43 patients who underwent isolated mitral valve replacement (MVR); Group II, 27 patients who had isolated aortic valve replacement (AVR); Group III, 10 patients who had MVR and AVR; and Group IV, 20 patients who had MVR or AVR associated with other cardiac procedures. The operative mortality for Group I was 2.3% (1 of 43) and 15% (3 of 20) in Group IV. The total operative mortality was 4% (4...
181.
